Literature DB >> 299666

Lumbar myelography.

G Dugstad1, P Eldevik.   

Abstract

The total material of lumbar myelographies performed with metrizamide (Amipaque) up to November 1976 (48,000 examinations) has been reviewed to assess the incidence of side-effects. A detailed analysis of 2,457 examinations from Ullevål Sykehus has been performed in order to assess adverse effects and diagnostic reliability. Three epileptic seizures were recorded, two of these in known epileptics. The rate of minor side-effects was low and the diagnostic accuracy high.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 299666

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN： 0365-5954


  7 in total

1.  Relative efficacy of clinical examination, electromyography, plain film radiography, myelography and lumbar phlebography in the diagnosis of low back pain and sciatica.

Authors:  W Van Damme; G Hessels; M Verhelst; L Van Laer; I Van Es
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

Review 2.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

3.  Myelographic versus clinical diagnostics in lumbar disc disease.

Authors:  R Aejmelaeus; H Hiltunen; M Härkönen; M Silfverhuth; T Vähä-Tahlo; T Tunturi
Journal:  Arch Orthop Trauma Surg       Date:  1984

4.  Spasticity complicating metrizamide myelography.

Authors:  H M Earl; C J Earl; B E Kendall
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

5.  Epidurography in lumbar spondylolisthesis.

Authors:  J G Johansen; O Hauge
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

6.  Metrizamide lumbar epidurography with Seldinger Technique through the sacral notch and selective nerve root injection.

Authors:  H P Hatten
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

7.  Myelography with iohexol (Omnipaque); a clinical report with special reference to the adverse effects.

Authors:  I O Skalpe; P Nakstad
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.